TCI GENE Inc.

NT$34.65As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6879Healthcare
Country Taiwan
PE (Fwd) •••
TSR 5Y CAGR (18.29%)
Div yield 5.77%
ROE 5.55%
Biotechnology
Beta (5Y) 0.24
PE TTM 18.25
TSR TTM (12.28%)
Mkt cap NT$916.8M
ROIC 35.10%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$42
21.92%
120.07%
Hold 7|9|11|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.47
0.47
0.51
0.51
(4.47%)
(5.25%)
1.51%
3.37%
RevenueNT$M
48.55
49.19
49.82
51.93
(0.98%)
1.84%
6.14%
9.93%
Peers (US$27.69M)
Cap (US$)
PE
28.28M
—
27.68M
—
Capital
TTM
5Y
10Y
Leveragex
0.318
0.042
0.037
EBIT/Intx
0.189
0.140
0.141
Own earn%
77.36
(36.35)
(16.70)
Sh yield%
27.77
17.41
14.89
Owners
Insiders/Inst%
2.54
22.28
Short interest%
1.71
SBC / revenue%
3.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–2
$1 testx
—
Incr. ROIC%
10